Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sepset Biosciences
Vancouver, British Columbia, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
The SepsetER diagnostic test delivers rapid (~1 hour) identification of patients at high risk of developing sepsis, outperforming conventional diagnostics (which can take >15 hours), enabling early intervention and reduced mortality; recent multi-center studies in 4 countries confirm high accuracy, sensitivity, and specificity
- Therapeutic areas
- NephrologyCardiovascularInfectious DiseasesGastroenterology
- Modalities
- Diagnostic assayGene expression testIn vitro diagnostic
- Industry
- Molecular Diagnostics
02
Partnerships
Sansure Biotech (joint venture “SepSMART” in China for manufacturing/commercialization)adMare BioInnovations (original spinout and early support)
Beyond the preview
Go deeper on Sepset Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sepset Biosciences.